This Week
- Symrise to debut clinical evidence for acerola beauty ingredient at SupplySide Global
- UK MPs call for NHS obesity overhaul as black-market GLP-1s and childhood obesity rise
- Clasado Biosciences secures ACI Group as UK and Irish distributor for Bimuno GOS prebiotic
- IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
- UK groups urge Healthy Start expansion after 750,000 pregnant women and children miss out
- Menopause supplements need women-only trials to move beyond wellness claims
- Protein, fiber & taste drive next wave of GLP-1 companion nutrition
- Abbott to spin off US$8.5B Nutrition business behind Ensure and Similac
- Oobli expands sweet protein pipeline with miraculin to target metabolic health
- Brevel & The Wave Group to build 300,000 L illuminated fermentation plant in India
- Roquette backs pharma-grade excipients as OTC and consumer health converge
- Rousselot launches Nextida NxCogni collagen peptide for cognitive resilience
- NOW launches GLP-1 metabolic support supplement for blood sugar and satiety
- Calcium-rich whey permeate maintains bone density in postmenopausal women, trial finds
- GLP-1 companion nutrition must complement drugs, not compete, suppliers urge
- Better Dairy secures self-affirmed GRAS for precision-fermented lactopontin in the US
- India’s food safety watchdog proposes ban on added sugars in infant formula
- Kirin eyes allergy-relief foods after postbiotic eases hay fever symptoms in trial
- SupplySide Global 2026: AstaReal targets longevity and active nutrition with astaxanthin
- Nestlé backs WSSO initiative to tackle malnutrition in cancer surgery patients
- Children’s caffeine intake linked to brain differences and poorer mental health
- Cargill prioritizes whole-system formulation over hero ingredients for everyday nutrition
